Company / Operating Income per Share
Intellia Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.32
FY2025
5-year range
-$5.92 / -$1.61
FY2021-FY2025
Trend
+24.8%
vs FY2024
Sector context
#147 of 154
Health Care
What the data says
Among 154 Health Care companies, Intellia Therapeutics, Inc. is in the bottom 5% for operating income per share. Operating Income per Share has fluctuated over the past 10 years, ranging from $-5.92 in FY2023 to $-0.76 in FY2018.
Based on SEC 10-K filings.
-4.32 in FY2025.
Improved from $-5.92 to $-4.32 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 154This company -$4.32 Sector average $4.25
▼
-201.6% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 24.8% year-over-year.
- Ranks #147 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.32 | +24.8% |
| FY2024 | -$5.74 | +2.9% |
| FY2023 | -$5.92 | -222.6% |
| FY2022 | -$1.83 | -14.2% |
| FY2021 | -$1.61 | +41.0% |
| FY2020 | -$2.72 | -76.9% |
| FY2019 | -$1.54 | -102.7% |
| FY2018 | -$0.76 | +60.7% |
| FY2017 | -$1.93 | -33.5% |
| FY2016 | -$1.45 | +97.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026